INmune Bio Inc. (INMB)

INmune Bio Stock Forecast

INMB's stock price has decreased by -85.47% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts that cover INmune Bio stock have a consensus rating of "Buy" and an average price target of $5.87, which forecasts a 410.43% increase in the stock price over the next year. The lowest target is $0.60 and the highest is $9.00.

Price Target: $5.87 (+410.43%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$0.60	$5.87	$8.00	$9.00
Change	-47.83%	+410.43%	+595.65%	+682.61%

Analyst Ratings

The average analyst rating for INmune Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elemer Piros LUCID CAPITAL MARKETS	LUCID CAPITAL MARKETS	Hold → Strong Buy Upgrades $2 → $9	Hold → Strong Buy	Upgrades	$2 → $9	+682.61%	Mar 11, 2026
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $30 → $8	Strong Buy	Maintains	$30 → $8	+595.65%	Jul 2, 2025
Thomas Shrader BTIG	BTIG	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 1, 2025
George Farmer Scotiabank	Scotiabank	Buy → Sell Downgrades $23 → $0.6	Buy → Sell	Downgrades	$23 → $0.6	-47.83%	Jul 1, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $22 → $30	Strong Buy	Maintains	$22 → $30	+2,508.70%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

51.00K

Increased by 264.29%

from 14.00K

Revenue Next Year

n/a

from 51.00K

EPS This Year

-1.96

from -2.11

EPS Next Year

-0.94

from -1.96

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	11.00K	181.00K	374.00K	155.00K	14.00K	51.00K	-
Revenue Growth	-	1,545.46%	106.63%	-58.56%	-90.97%	264.29%	-
EPS	-1.01	-1.88	-1.52	-1.67	-2.11	-1.96	-0.94
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	52,500	n/a
Avg	51,000	n/a
Low	49,000	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	275.0%	-
Avg	264.3%	-
Low	250.0%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.02	-0.76
Avg	-1.96	-0.94
Low	-1.88	-1.09

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.